Global Vaccines Market & Forecasts Report 2011-2022

Dublin, Nov. 01, 2017 -- The "Global Vaccines Market & Forecast (14 Vaccines Market, Number of People Immunized Doses of Vaccines Administered)" report has been added to Research and Markets' offering.

Global Vaccines Market to reach US$ 60 Billion by 2022

Pediatric vaccines market is having a dominant market share compared to Adult vaccines market. By 2022 Pediatric vaccines market share will be double the size of adult vaccines market share. Worldwide the number of infants immunized by influenza vaccines remain considerably low than that of adults immunized in year 2017. While the number of Rotavirus doses administered in infants is forecast to increase over the years and reach nearly 15 Million by the year 2022.

Out of the total 9 Adult vaccines (Influenza, Cervical Cancer, Zoster, MMRV, Pneumococcal, Meningococcal, Hepatitis, TdaP, Travel) studied in the report Influenza vaccines dominates the adult vaccine market in 2017.

Analysis found that in year 2017; Pneumococcal and Combination vaccine together accounts for nearly 50% of the pediatric vaccine market share. Other Pediatric vaccines market studied in the report are as follows: Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTap, Haemophilus Influenzae Type b(Hib), Combos, Polio, Rotavirus, Varicella.

For the year 2017; Combos (Combination Vaccines) has the maximum immunization share among all pediatric vaccines (Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTap, Haemophilus Influenzae Type b(Hib), Polio, Rotavirus, Varicella) studied in the report as they protect against more ailments in single shot, people preferring to get combination vaccine instead of a specific vaccine.

Vaccine has been extensively studied from 3 major points, and further sub-divided into 2 more points:

• World Vaccines (Disease wise) Market & Forecast (2011 - 2022)
  • Adult Vaccines Market & Forecast
  • Pediatrics Vaccines Market & Forecast
• People Immunized (Disease wise) & Forecast (2011 - 2022)
  • Adult Immunized & Forecast
  • Pediatric (Infants) Immunized & Forecast
• Doses of Vaccines Administered (Disease wise) & Forecast (2011 - 2022)
  • Doses of vaccines administered in Adults & Forecast
  • Doses of vaccines administered in Pediatric (Infants) & Forecast

14 Vaccines Studied in the Report are as Follows:

1. Influenza
2. Cervical Cancer
3. Zoster (Shingles)
4. MMR (Measles, Mumps, and Rubella)
5. Pneumonia
6. Meningitis
7. Hepatitis
8. Tap (Diphtheria, Tetanus, Pertussis)
9. Haemophilus influenzae type B
10. Polio
11. Rotavirus
12. Varicella
13. Combination Vaccine
14. Travel & Miscellaneous Vaccine

Key Topics Covered:

1 Research Findings

2 Global - Vaccines Market and Forecast
2.1 Adult Vaccines Market and Forecast
2.2 Pediatric (Infant) Vaccines Market and Forecast

3 Global - Adult Vaccine vs. Pediatric Vaccine Market Share

4 Global - Vaccines Market Share and Forecast
4.1 Adult Vaccines Market Share and Forecast
4.2 Pediatric (Infant) Vaccines Market Share and Forecast

5 Global - People Immunized and Forecast
5.1 Adult Immunized and Forecast
5.2 Pediatric (Infant) Immunized and Forecast

6 Global - People Immunized Share and Forecast
6.1 Adult Immunized Share and Forecast
6.2 Pediatric (Infant) Immunized Share and Forecast

7 Global - Doses of Vaccines Administered and Forecast
7.1 Doses of Adult Vaccines Administered and Forecast
7.2 Doses of Pediatric (Infant) Vaccines Administered and Forecast

8 Global - Doses of Vaccines Administered Share and Forecast
8.1 Doses of Vaccines Administered to Adult Share and Forecast
8.2 Doses of Vaccines Administered to Pediatric (Infant) Share and Forecast

9 Global - Vaccine Companies Market Share and Forecast

10 Disease wise - Vaccines Market and Forecast
10.1 Influenza - Total Vaccines Market and Forecast
10.1.1 Influenza - Adult Vaccines Market and Forecast
10.1.2 Influenza - Pediatric (Infant) Vaccines Market and Forecast
10.2 Cervical Cancer (HPV) - Vaccines Market and Forecast
10.3 Zoster (Shingles) - Vaccines Market and Forecast
10.4 MMRV and MMR (Measles, Mumps, Rubella, and Varicella Vaccine) - Total Vaccines Market and Forecast
10.4.1 MMRV - Adult Vaccines Market and Forecast
10.4.2 MMR - Pediatric (Infant) Vaccines Market and Forecast
10.5 Pneumococcal - Total Vaccines Market and Forecast
10.5.1 Pneumococcal - Adult Vaccines Market and Forecast
10.5.2 Pneumococcal - Pediatric (Infant) Vaccines Market and Forecast
10.6 Meningococcal - Total Vaccines Market and Forecast
10.6.1 Meningococcal - Adult Vaccines Market and Forecast
10.6.2 Meningococcal - Pediatric (Infant) Vaccines Market and Forecast
10.7 Hepatitis - Total Vaccines Market and Forecast
10.7.1 Hepatitis - Adult Vaccines Market and Forecast
10.7.2 Hepatitis - Pediatric (Infant) Vaccines Market and Forecast
10.8 TdaP and DTaP - Total Vaccines Market and Forecast
10.8.1 TdaP - Adult Vaccines Market and Forecast
10.8.2 DTaP - Pediatric (Infant) Vaccines Market and Forecast
10.9 Travel and Miscellaneous - Vaccines Market and Forecast
10.1 Haemophilus Influenzae Type B (HIB) - Vaccines Market and Forecast
10.11 Combos (Combination) - Vaccines Market and Forecast
10.12 Polio - Vaccines Market and Forecast
10.13 Rotavirus - Vaccines Market and Forecast
10.14 Varicella - Vaccines Market and Forecast

11 Disease wise - People Immunized Numbers and Forecast
11.1 Influenza - Total Number of People Immunized and Forecast
11.1.1 Influenza - Number of Adults Immunized and Forecast
11.1.2 Influenza - Number of Infants Immunized and Forecast
11.2 Cervical Cancer (HPV) - People Immunized and Forecast
11.3 Zoster (Shingles) - Number of People Immunized and Forecast
11.4 MMRV and MMR - Total Number of People Immunized and Forecast
11.4.1 MMRV - Number of Adults Immunized and Forecast
11.4.2 MMR - Number of Pediatric (Infants) Immunized and Forecast
11.5 Pneumococcal - Total Number of People Immunized and Forecast
11.5.1 Pneumococcal - Number of Adults Immunized and Forecast
11.5.2 Pneumococcal - Number of Infants Immunized and Forecast
11.6 Meningococcal - Total Number of People Immunized and Forecast
11.6.1 Meningococcal - Number of Adults Immunized and Forecast
11.6.2 Meningococcal - Number of Infants Immunized and Forecast
11.7 Hepatitis - Total Number of People Immunized and Forecast
11.7.1 Hepatitis - Number of Adults Immunized and Forecast
11.7.2 Hepatitis - Number of Infants Immunized and Forecast
11.8 TdaP and DTaP - Total Number of People Immunized and Forecast
11.8.1 TdaP - Number of Adults Immunized and Forecast
11.8.2 DTaP - Number of Infants Immunized and Forecast
11.9 Hib (Haemophilus Influenzae Type B) - Number of Infants Immunized and Forecast
11.1 Combos (Combination Vaccines) - Number of Infants Immunized and Forecast
11.11 Polio - Number of Infants Immunized and Forecast
11.12 Rotavirus - Number of Infants Immunized and Forecast
11.13 Varicella - Number of Infants Immunized and Forecast

12 Disease wise - Doses of Vaccines Administered and Forecast
12.1 Influenza - Doses of Vaccines Administered and Forecast
12.1.1 Influenza - Doses of Adult Vaccines Administered and Forecast
12.1.2 Influenza - Doses of Infant Vaccines Administered and Forecast
12.2 Cervical Cancer (HPV) - Doses of Vaccines Administered and Forecast
12.3 Zoster (Shingles) - Doses of Vaccines Administered and Forecast
12.4 MMRV and MMR - Doses of Vaccines Administered and Forecast
12.4.1 MMRV - Doses of Adult Vaccines Administered and Forecast
12.4.2 MMR - Doses of Infant Vaccines Administered and Forecast
12.5 Pneumococcal - Doses of Vaccines Administered and Forecast
12.5.1 Pneumococcal - Doses of Adult Vaccines Administered and Forecast
12.5.2 Pneumococcal - Doses of Infant Vaccines Administered and Forecast
12.6 Meningococcal - Doses of Vaccines Administered and Forecast
12.6.1 Meningococcal - Doses of Adult Vaccines Administered and Forecast
12.6.2 Meningococcal - Doses of Infant Vaccines Administered and Forecast
12.7 Hepatitis - Doses of Vaccines Administered and Forecast
12.7.1 Hepatitis - Doses of Adult Vaccines Administered and Forecast
12.7.2 Hepatitis - Doses of Infant Vaccines Administered and Forecast
12.8 TdaP and DTaP - Doses of Vaccines Administered and Forecast
12.8.1 TdaP - Doses of Adult Vaccines Administered and Forecast
12.8.2 DTaP - Doses of Infant Vaccines Administered and Forecast
12.9 Hib (Haemophilus Influenzae Type B) - Doses of Infant Vaccines Administered and Forecast
12.1 Polio - Doses of Infant Vaccines Administered and Forecast
12.11 Rotavirus - Doses of Infant Vaccines Administered and Forecast
12.12 Varicella - Doses of Infant Vaccines Administered and Forecast

13 Disease wise - Immunization Profile
13.1 Immunization Coverage (%) in Infants (2005 - 2015)
13.2 Global Immunization Profile (2011 - 2015)
13.3 Regional Immunization Profile (2001 - 2015)
13.3.1 Measles - Number of Cases Reported
13.3.2 Mumps - Number of Cases Reported
13.3.3 Rubella - Number of Cases Reported
13.3.4 Rubella (CRS) - Number of Cases Reported
13.3.5 Diphtheria - Number of Cases Reported
13.3.6 Tetanus (Neonatal) - Number of Cases Reported
13.3.7 Tetanus (Total) - Number of Cases Reported
13.3.8 Pertussis - Number of Cases Reported
13.3.9 Polio - Number of Cases Reported
13.3.10 Yellow Fever - Number of Cases Reported
13.3.11 Japanese encephalitis - Number of Cases Reported, 2006 - 2015

14 Vaccines Key Players Sales and Forecast
14.1 GlaxoSmithKline, plc.'s Vaccines Sales and Forecast
14.2 Merck & Co. Vaccines Sales and Forecast
14.3 Sanofi Pasteur's (France) Vaccines Sales and Forecast
14.4 Worldwide - Pfizer, Inc.'s Vaccines Sales and Forecast
14.5 Worldwide - Others Vaccines Sales and Forecast

15 Vaccines - Products and Pipeline
15.1 GSK Vaccine Product Pipeline
15.2 Merck Vaccine Product Pipeline
15.3 Sanofi Vaccine Product Pipeline
15.4 Pfizer Vaccine Product Pipeline

16 Top Mergers and Acquisitions in the Vaccine Industry

17 Vaccines and Regulator's Interventions
17.1 Making and Meeting Standards of Quality and Safety
17.2 Vaccine Funding

18 Vaccine Market Drivers
18.1 Inclusion in National Immunization Schedule
18.2 Growing Immunization Coverage for HPV Vaccines
18.3 Increase in Prevalence of Infectious Diseases
18.4 Global Immunization Vision and Strategy (GIVS)
18.5 GAVI Model Fuelling Vaccine Manufacturers
18.5.1 The Partnership Model
18.5.2 The Business Model
18.6 Increasing Vaccine Availability in United States
18.7 The Vaccine Safety Data link Project
18.8 The Vaccine Injury Compensation Program
18.9 Transforming of Vaccine Technologies
18.1 Global Vaccine Action Plan by WHO (2011 - 2020)
18.11 Continuous Focus on Effective Communication Strategies

19 Vaccines Market Challenges
19.1 Hurdles to Optimal use of Licensed Vaccines
19.1.1 Technical Obstacles
19.1.2 Economic Obstacles
19.1.3 Cultural Obstacles
19.2 Complexity of Vaccine Development & Approval System Thwarts Product Development
19.2.1 Legal Obstacles
19.2.2 General Technical Barriers
19.2.3 Economic Barriers
19.2.4 Regulatory Barriers
19.3 Shortening the Timeline for Vaccine Development
19.4 Refusal/Resistance to Vaccination
19.4.1 Vaccine Adverse Event Reporting System
19.5 Vaccine Shortages and Delays
19.6 Obstacles in Vaccine Research & Development
19.7 Barriers to New Entrants in the Vaccines Market

For more information about this report visit https://www.researchandmarkets.com/research/4cmxhx/global_vaccines

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Vaccines